Anthony H Nguyen

Array ( [id] => 6788121 [patent_doc_number] => 20030139360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'ANTISENSE MODULATION OF ESTROGEN RECEPTOR ALPHA EXPRESSION' [patent_app_type] => new [patent_app_number] => 10/027983 [patent_app_country] => US [patent_app_date] => 2001-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27652 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139360.pdf [firstpage_image] =>[orig_patent_app_number] => 10027983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232801 [patent_doc_number] => 07598226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Compositions and methods for the therapy and diagnosis of breast cancer' [patent_app_type] => utility [patent_app_number] => 10/007805 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 52528 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598226.pdf [firstpage_image] =>[orig_patent_app_number] => 10007805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788120 [patent_doc_number] => 20030139359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Antisense modulation of phospholipid scramblase 3 expression' [patent_app_type] => new [patent_app_number] => 10/006972 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27028 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139359.pdf [firstpage_image] =>[orig_patent_app_number] => 10006972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157958 [patent_doc_number] => 20020146829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Neutral and anionic colloidal particles for gene delivery' [patent_app_type] => new [patent_app_number] => 09/996838 [patent_app_country] => US [patent_app_date] => 2001-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5442 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146829.pdf [firstpage_image] =>[orig_patent_app_number] => 09996838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6741034 [patent_doc_number] => 20030158403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Nuclease resistant chimeric oligonucleotides' [patent_app_type] => new [patent_app_number] => 09/996292 [patent_app_country] => US [patent_app_date] => 2001-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 34965 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158403.pdf [firstpage_image] =>[orig_patent_app_number] => 09996292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846682 [patent_doc_number] => 20030165849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Methods and reagents for introducing a sulfhydryl group into the 5\'-terminus of RNA' [patent_app_type] => new [patent_app_number] => 09/996139 [patent_app_country] => US [patent_app_date] => 2001-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16403 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165849.pdf [firstpage_image] =>[orig_patent_app_number] => 09996139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761910 [patent_doc_number] => 20030125272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Antisense modulation of toll-like receptor 4 expression' [patent_app_type] => new [patent_app_number] => 10/001863 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24193 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125272.pdf [firstpage_image] =>[orig_patent_app_number] => 10001863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240628 [patent_doc_number] => 06686442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'Conjugated peptide nucleic acids having enhanced cellular uptake' [patent_app_type] => B2 [patent_app_number] => 09/997629 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19128 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686442.pdf [firstpage_image] =>[orig_patent_app_number] => 09997629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 739866 [patent_doc_number] => 07029665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Human suppressor tRNA oligonucleotides and methods for use for same' [patent_app_type] => utility [patent_app_number] => 10/022127 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 23 [patent_no_of_words] => 12256 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/029/07029665.pdf [firstpage_image] =>[orig_patent_app_number] => 10022127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636809 [patent_doc_number] => 20020086849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Method for introducing antisense oligonucleotides into eucaryotic cells' [patent_app_type] => new [patent_app_number] => 09/984076 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9504 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086849.pdf [firstpage_image] =>[orig_patent_app_number] => 09984076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651300 [patent_doc_number] => 20030105044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Antisense modulation of matrix metalloproteinase 1 expression' [patent_app_type] => new [patent_app_number] => 10/035485 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24947 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105044.pdf [firstpage_image] =>[orig_patent_app_number] => 10035485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922955 [patent_doc_number] => 20020115606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Protein-protein interactions in neurodegenerative diseases' [patent_app_type] => new [patent_app_number] => 09/973964 [patent_app_country] => US [patent_app_date] => 2001-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27407 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115606.pdf [firstpage_image] =>[orig_patent_app_number] => 09973964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651272 [patent_doc_number] => 20030105037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Antisense modulation of inhibitor-kappa B kinase-gamma expression' [patent_app_type] => new [patent_app_number] => 09/972607 [patent_app_country] => US [patent_app_date] => 2001-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26420 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105037.pdf [firstpage_image] =>[orig_patent_app_number] => 09972607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416700 [patent_doc_number] => 06514717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-04 [patent_title] => 'Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes' [patent_app_type] => B2 [patent_app_number] => 09/960932 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3976 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514717.pdf [firstpage_image] =>[orig_patent_app_number] => 09960932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6259846 [patent_doc_number] => 20020187482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Methods and means of RNA analysis' [patent_app_type] => new [patent_app_number] => 09/961700 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7907 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187482.pdf [firstpage_image] =>[orig_patent_app_number] => 09961700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5787004 [patent_doc_number] => 20020160379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Gapped 2\' modified oligonucleotides' [patent_app_type] => new [patent_app_number] => 09/951052 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13564 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160379.pdf [firstpage_image] =>[orig_patent_app_number] => 09951052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6693186 [patent_doc_number] => 20030040618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Photocleavable protecting groups' [patent_app_type] => new [patent_app_number] => 09/950982 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 11584 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040618.pdf [firstpage_image] =>[orig_patent_app_number] => 09950982 [rel_patent_id] =>[rel_patent_doc_number] =>)